Ultrasensitive Detection of SARS-CoV-2 Spike Proteins Using the Thio-NAD Cycling Reaction: A Preliminary Study before Clinical Trials
- PMID: 34835340
- PMCID: PMC8619787
- DOI: 10.3390/microorganisms9112214
Ultrasensitive Detection of SARS-CoV-2 Spike Proteins Using the Thio-NAD Cycling Reaction: A Preliminary Study before Clinical Trials
Abstract
To help control the global pandemic of coronavirus disease 2019 (COVID-19), we developed a diagnostic method targeting the spike protein of the virus that causes the infection, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We applied an ultrasensitive method by combining a sandwich enzyme-linked immunosorbent assay (ELISA) and the thio-nicotinamide adenine dinucleotide (thio-NAD) cycling reaction to quantify spike S1 proteins. The limit of detection (LOD) was 2.62 × 10-19 moles/assay for recombinant S1 proteins and 2.6 × 106 RNA copies/assay for ultraviolet B-inactivated viruses. We have already shown that the ultrasensitive ELISA for nucleocapsid proteins can detect ultraviolet B-inactivated viruses at the 104 RNA copies/assay level, whereas the nucleocapsid proteins of SARS-CoV-2 are difficult to distinguish from those in conventional coronaviruses and SARS-CoV. Thus, an antigen test for only the nucleocapsid proteins is insufficient for virus specificity. Therefore, the use of a combination of tests against both spike and nucleocapsid proteins is recommended to increase both the detection sensitivity and testing accuracy of the COVID-19 antigen test. Taken together, our present study, in which we incorporate S1 detection by combining the ultrasensitive ELISA for nucleocapsid proteins, offers an ultrasensitive, antigen-specific test for COVID-19.
Keywords: COVID-19; SARS-CoV-2; antigen test; spike protein; thio-NAD cycling; ultrasensitive ELISA.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Improved Detection Sensitivity of an Antigen Test for SARS-CoV-2 Nucleocapsid Proteins with Thio-NAD Cycling.Biol Pharm Bull. 2021 Sep 1;44(9):1332-1336. doi: 10.1248/bpb.b21-00387. Epub 2021 Jun 19. Biol Pharm Bull. 2021. PMID: 34148926
-
Proposal of De Novo Antigen Test for COVID-19: Ultrasensitive Detection of Spike Proteins of SARS-CoV-2.Diagnostics (Basel). 2020 Aug 14;10(8):594. doi: 10.3390/diagnostics10080594. Diagnostics (Basel). 2020. PMID: 32823866 Free PMC article.
-
Ultrasensitive enzyme-linked immunosorbent assay (ELISA) of proteins by combination with the thio-NAD cycling method.Biophysics (Nagoya-shi). 2014 Sep 5;10:49-54. doi: 10.2142/biophysics.10.49. eCollection 2014. Biophysics (Nagoya-shi). 2014. PMID: 27493498 Free PMC article.
-
Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective.J Clin Microbiol. 2021 Apr 20;59(5):e02160-20. doi: 10.1128/JCM.02160-20. Print 2021 Apr 20. J Clin Microbiol. 2021. PMID: 33318065 Free PMC article. Review.
-
Ultrasensitive ELISA Developed for Diagnosis.Diagnostics (Basel). 2019 Jul 18;9(3):78. doi: 10.3390/diagnostics9030078. Diagnostics (Basel). 2019. PMID: 31323782 Free PMC article. Review.
Cited by
-
Modified ELISA for Ultrasensitive Diagnosis.J Clin Med. 2021 Nov 7;10(21):5197. doi: 10.3390/jcm10215197. J Clin Med. 2021. PMID: 34768717 Free PMC article. Review.
-
Advanced Detection Method for Dengue NS1 Protein Using Ultrasensitive ELISA with Thio-NAD Cycling.Viruses. 2023 Sep 8;15(9):1894. doi: 10.3390/v15091894. Viruses. 2023. PMID: 37766300 Free PMC article.
-
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast.Int J Mol Sci. 2022 Jul 30;23(15):8485. doi: 10.3390/ijms23158485. Int J Mol Sci. 2022. PMID: 35955621 Free PMC article. Review.
-
Ultrasensitive protein-level detection for respiratory infectious viruses.Front Immunol. 2024 Dec 2;15:1445771. doi: 10.3389/fimmu.2024.1445771. eCollection 2024. Front Immunol. 2024. PMID: 39687610 Free PMC article.
-
Ultrasensitive Detection of GRP78 in Exosomes and Observation of Migration and Proliferation of Cancer Cells by Application of GRP78-Containing Exosomes.Cancers (Basel). 2022 Aug 11;14(16):3887. doi: 10.3390/cancers14163887. Cancers (Basel). 2022. PMID: 36010879 Free PMC article.
References
-
- Premkumar L., Segovia-Chumbez B., Jadi R., Martinez D.R., Raut R., Markmann A., Cornaby C., Bartelt L., Weiss S., Park Y., et al. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Sci. Immunol. 2020;5:eabc8413. doi: 10.1126/sciimmunol.abc8413. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous